Sorry, you need to enable JavaScript to visit this website.
Search
March 11, 2022

CDC-Abt Study Shows Pfizer Vaccine Is Moderately Effective for Children

Body

More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.

Read More

COVID-19 in North America

Building an AI-Enabled Platform for Federal Data Analysis

Abt Digital Solutions built the Dynamic Soils Hub to modernize how USDA analyzes and applies soil data for conservation impact.

Learn More
Impact Brief

From Experiment to Action: How Medicare is Transforming Cancer Care

Cancer is one of the most expensive and complex conditions to treat. But can better care for cancer patients also cost less?

Learn More
Impact Brief

Coastal Resilience Powered by Open Data and Modern Tools

For the Department of the Interior, streamlined data access and user-friendly tools that strengthen coastal protection, marine minerals access, and environmental resilience. ​

Learn More
Impact Brief

Addressing Cumulative Air Pollution in Massachusetts

Supporting Massachusetts in developing cumulative impact analysis and protective air permitting tools.

Learn More
Impact Brief